Results 11 to 20 of about 6,869 (208)
Anidulafungin-Induced Suicidal Erythrocyte Death
Cellular Physiology and Biochemistry, 2016 Background/Aims: The novel antifungal drug Anidulafungin is used for the treatment of diverse fungal infections including candidiasis and aspergillosis.
Thomas Peter +3 more
doaj +2 more sources
Brazilian Journal of Pharmaceutical Sciences, 2019 Candida glabrata has emerged as a common cause of serious life-threatening fungal infections, largely owing to their low susceptibility to azole antifungals. Recent guidance indicates the use of echinocandins as the first-choice drug for the treatment of
Camila Hatwig +5 more
doaj +3 more sources
Anidulafungin induced reversible thrombocytopenia in a patient: A case report
Medicine Science, 2018 Anidulafungin is a semisynthetic antifungal agent which is an echinocandin. Here, we presented elderly patient developed reversible severe thrombocytopenia due to anidulafungin.
Zubeyir Cebeci +3 more
doaj +2 more sources
Anidulafungin in the treatment of invasive fungal infections
Therapeutics and Clinical Risk Management, 2008 Kathryn Sabol, Tawanda GumboUniversity of Texas Southwestern Medical Center, Dallas, TX, USAAbstract: More antifungal agents have reached clinical use in the past two decades than at any other time.
Kathryn Sabol, Tawanda Gumbo
doaj +1 more source
Anidulafungin for the treatment of invasive candidiasis [PDF]
Clinical Microbiology and Infection, 2011 Candidaemia/invasive candidiasis (C/IC) is the most frequently occurring invasive fungal infection worldwide, with a particularly strong impact and high incidence in the intensive-care unit, where there is a need for new treatment options and strategies. The echinocandin anidulafungin has broad in vitro activity against a wide range of Candida species,
Mayr, A., Aigner, M., Lass-Flörl, C.
openaire +4 more sources
Therapeutic Advances in Infectious DiseaseBackground: Echinocandins are recommended as an initial treatment for invasive candidiasis. Although safety and efficacy profiles of both anidulafungin and caspofungin are well established, direct head-to-head comparisons have not been reported before ...
Reem Hasan Elajez +10 more
doaj +2 more sources
Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis [PDF]
International Journal of Infectious Diseases, 2019 Objective: To describe the pharmacokinetic (PK) profile of anidulafungin and to evaluate its concentration in the peritoneal fluid (PF) of patients suspected of suffering from peritoneal infection undergoing abdominal surgery, in order to ensure that ...
D.V. Pérez Civantos +5 more
doaj +2 more sources
Anidulafungin and its role in candida infections
Infection and Drug Resistance, 2009 Diane M Cappelletty, Rose JungThe University of Toledo, College of Pharmacy, Toledo, OH, USAAbstract: Candida infections continue to play a significant role not only in critically ill and immunocompromised patients but also in non-compromised patients ...
Diane M Cappelletty, Rose Jung
doaj +1 more source
Human Tissue Distribution of Anidulafungin and Micafungin
, 2021 Concentrations of anidulafungin and micafungin were determined in eight different tissues obtained during autopsy of four deceased who had been treated with anidulafungin and of seven who had obtained micafungin.
Joannidis, Michael +5 more
core +1 more source
Journal of Global Antimicrobial Resistance, 2020 Introduction: Candida parapsilosis (C. parapsilosis) is a common non-albicans Candida species ranked as the second common cause of bloodstream infections. Azole resistance and elevated echinocandin MICs have been reported for these fungi.
Ali Ahmadi +11 more
doaj +1 more source